BioCardia, Inc. (BCDA)

BioCardia Statistics

Total Valuation

BioCardia has a market cap or net worth of $13.02 million. The enterprise value is $10.83 million.

Market Cap	13.02M
Enterprise Value	10.83M

Important Dates

The last earnings date was Tuesday, March 24, 2026, after market close.

Earnings Date	Mar 24, 2026
Ex-Dividend Date	n/a

Share Statistics

BioCardia has 10.94 million shares outstanding. The number of shares has increased by 142.98% in one year.

Current Share Class	10.61M
Shares Outstanding	10.94M
Shares Change (YoY)	+142.98%
Shares Change (QoQ)	+70.06%
Owned by Insiders (%)	20.52%
Owned by Institutions (%)	13.26%
Float	8.02M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	14.18
P/TBV Ratio	14.30
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.12, with a Debt / Equity ratio of 0.59.

Current Ratio	1.12
Quick Ratio	1.03
Debt / Equity	0.59
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -950.12% and return on invested capital (ROIC) is -322.25%.

Return on Equity (ROE)	-950.12%
Return on Assets (ROA)	-144.98%
Return on Invested Capital (ROIC)	-322.25%
Return on Capital Employed (ROCE)	-843.83%
Weighted Average Cost of Capital (WACC)	7.00%
Revenue Per Employee	n/a
Profits Per Employee	-$411,400
Employee Count	20
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	0.55
52-Week Price Change	n/a
50-Day Moving Average	1.24
200-Day Moving Average	1.58
Relative Strength Index (RSI)	42.52
Average Volume (20 Days)	70,738

Short Selling Information

The latest short interest is 218,108, so 1.99% of the outstanding shares have been sold short.

Short Interest	218,108
Short Previous Month	236,144
Short % of Shares Out	1.99%
Short % of Float	2.72%
Short Ratio (days to cover)	3.34

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-8.28M
Pretax Income	-8.23M
Net Income	-8.23M
EBITDA	-8.25M
EBIT	-8.28M
Earnings Per Share (EPS)	-$1.23

Balance Sheet

The company has $2.50 million in cash and $528,000 in debt, with a net cash position of $1.97 million or $0.18 per share.

Cash & Cash Equivalents	2.50M
Total Debt	528,000
Net Cash	1.97M
Net Cash Per Share	$0.18
Equity (Book Value)	895,000
Book Value Per Share	0.08
Working Capital	300,000

Cash Flow

In the last 12 months, operating cash flow was -$7.44 million and capital expenditures -$7,000, giving a free cash flow of -$7.44 million.

Operating Cash Flow	-7.44M
Capital Expenditures	-7,000
Depreciation & Amortization	24,000
Net Borrowing	n/a
Free Cash Flow	-7.44M
FCF Per Share	-$0.68

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BioCardia does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-142.98%
Shareholder Yield	-142.98%
Earnings Yield	-64.28%
FCF Yield	-58.15%

Analyst Forecast

The average price target for BioCardia is $25.00, which is 2,000.84% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$25.00
Price Target Difference	2,000.84%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	247.59%
EPS Growth Forecast (5Y)	-39.51%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 30, 2024. It was a reverse split with a ratio of 1:15.

Last Split Date	May 30, 2024
Split Type	Reverse
Split Ratio	1:15

Scores

Altman Z-Score	n/a
Piotroski F-Score	1